Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Hospital-acquired Infection Diagnostics Market Size Growth Rate by Type (2014-2025)
1.4.2 Instrument and Reagents
1.4.3 Consumables
1.5 Market by Application
1.5.1 Global Hospital-acquired Infection Diagnostics Market Share by Application (2014-2025)
1.5.2 Hospital
1.5.3 Clinics
1.5.4 Ambulatory Surgery Centers (ASC)
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Hospital-acquired Infection Diagnostics Market Size
2.2 Hospital-acquired Infection Diagnostics Growth Trends by Regions
2.2.1 Hospital-acquired Infection Diagnostics Market Size by Regions (2014-2025)
2.2.2 Hospital-acquired Infection Diagnostics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Hospital-acquired Infection Diagnostics Market Size by Manufacturers
3.1.1 Global Hospital-acquired Infection Diagnostics Revenue by Manufacturers (2014-2019)
3.1.2 Global Hospital-acquired Infection Diagnostics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Hospital-acquired Infection Diagnostics Market Concentration Ratio (CR5 and HHI)
3.2 Hospital-acquired Infection Diagnostics Key Players Head office and Area Served
3.3 Key Players Hospital-acquired Infection Diagnostics Product/Solution/Service
3.4 Date of Enter into Hospital-acquired Infection Diagnostics Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Hospital-acquired Infection Diagnostics Market Size by Type (2014-2019)
4.2 Global Hospital-acquired Infection Diagnostics Market Size by Application (2014-2019)
5 United States
5.1 United States Hospital-acquired Infection Diagnostics Market Size (2014-2019)
5.2 Hospital-acquired Infection Diagnostics Key Players in United States
5.3 United States Hospital-acquired Infection Diagnostics Market Size by Type
5.4 United States Hospital-acquired Infection Diagnostics Market Size by Application
6 Europe
6.1 Europe Hospital-acquired Infection Diagnostics Market Size (2014-2019)
6.2 Hospital-acquired Infection Diagnostics Key Players in Europe
6.3 Europe Hospital-acquired Infection Diagnostics Market Size by Type
6.4 Europe Hospital-acquired Infection Diagnostics Market Size by Application
7 China
7.1 China Hospital-acquired Infection Diagnostics Market Size (2014-2019)
7.2 Hospital-acquired Infection Diagnostics Key Players in China
7.3 China Hospital-acquired Infection Diagnostics Market Size by Type
7.4 China Hospital-acquired Infection Diagnostics Market Size by Application
8 Japan
8.1 Japan Hospital-acquired Infection Diagnostics Market Size (2014-2019)
8.2 Hospital-acquired Infection Diagnostics Key Players in Japan
8.3 Japan Hospital-acquired Infection Diagnostics Market Size by Type
8.4 Japan Hospital-acquired Infection Diagnostics Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Hospital-acquired Infection Diagnostics Market Size (2014-2019)
9.2 Hospital-acquired Infection Diagnostics Key Players in Southeast Asia
9.3 Southeast Asia Hospital-acquired Infection Diagnostics Market Size by Type
9.4 Southeast Asia Hospital-acquired Infection Diagnostics Market Size by Application
10 India
10.1 India Hospital-acquired Infection Diagnostics Market Size (2014-2019)
10.2 Hospital-acquired Infection Diagnostics Key Players in India
10.3 India Hospital-acquired Infection Diagnostics Market Size by Type
10.4 India Hospital-acquired Infection Diagnostics Market Size by Application
11 Central & South America
11.1 Central & South America Hospital-acquired Infection Diagnostics Market Size (2014-2019)
11.2 Hospital-acquired Infection Diagnostics Key Players in Central & South America
11.3 Central & South America Hospital-acquired Infection Diagnostics Market Size by Type
11.4 Central & South America Hospital-acquired Infection Diagnostics Market Size by Application
12 International Players Profiles
12.1 Abbott Laboratories
12.1.1 Abbott Laboratories Company Details
12.1.2 Company Description and Business Overview
12.1.3 Hospital-acquired Infection Diagnostics Introduction
12.1.4 Abbott Laboratories Revenue in Hospital-acquired Infection Diagnostics Business (2014-2019)
12.1.5 Abbott Laboratories Recent Development
12.2 Advan DX
12.2.1 Advan DX Company Details
12.2.2 Company Description and Business Overview
12.2.3 Hospital-acquired Infection Diagnostics Introduction
12.2.4 Advan DX Revenue in Hospital-acquired Infection Diagnostics Business (2014-2019)
12.2.5 Advan DX Recent Development
12.3 Alere Inc.
12.3.1 Alere Inc. Company Details
12.3.2 Company Description and Business Overview
12.3.3 Hospital-acquired Infection Diagnostics Introduction
12.3.4 Alere Inc. Revenue in Hospital-acquired Infection Diagnostics Business (2014-2019)
12.3.5 Alere Inc. Recent Development
12.4 Astrazeneca PLC
12.4.1 Astrazeneca PLC Company Details
12.4.2 Company Description and Business Overview
12.4.3 Hospital-acquired Infection Diagnostics Introduction
12.4.4 Astrazeneca PLC Revenue in Hospital-acquired Infection Diagnostics Business (2014-2019)
12.4.5 Astrazeneca PLC Recent Development
12.5 Bayer Schering Pharma LLC
12.5.1 Bayer Schering Pharma LLC Company Details
12.5.2 Company Description and Business Overview
12.5.3 Hospital-acquired Infection Diagnostics Introduction
12.5.4 Bayer Schering Pharma LLC Revenue in Hospital-acquired Infection Diagnostics Business (2014-2019)
12.5.5 Bayer Schering Pharma LLC Recent Development
12.6 Becton Dickinson And Company
12.6.1 Becton Dickinson And Company Company Details
12.6.2 Company Description and Business Overview
12.6.3 Hospital-acquired Infection Diagnostics Introduction
12.6.4 Becton Dickinson And Company Revenue in Hospital-acquired Infection Diagnostics Business (2014-2019)
12.6.5 Becton Dickinson And Company Recent Development
12.7 Cepheid Inc.
12.7.1 Cepheid Inc. Company Details
12.7.2 Company Description and Business Overview
12.7.3 Hospital-acquired Infection Diagnostics Introduction
12.7.4 Cepheid Inc. Revenue in Hospital-acquired Infection Diagnostics Business (2014-2019)
12.7.5 Cepheid Inc. Recent Development
12.8 Roche AG
12.8.1 Roche AG Company Details
12.8.2 Company Description and Business Overview
12.8.3 Hospital-acquired Infection Diagnostics Introduction
12.8.4 Roche AG Revenue in Hospital-acquired Infection Diagnostics Business (2014-2019)
12.8.5 Roche AG Recent Development
12.9 Daiichi Sankyo
12.9.1 Daiichi Sankyo Company Details
12.9.2 Company Description and Business Overview
12.9.3 Hospital-acquired Infection Diagnostics Introduction
12.9.4 Daiichi Sankyo Revenue in Hospital-acquired Infection Diagnostics Business (2014-2019)
12.9.5 Daiichi Sankyo Recent Development
12.10 Hologic, Inc.
12.10.1 Hologic, Inc. Company Details
12.10.2 Company Description and Business Overview
12.10.3 Hospital-acquired Infection Diagnostics Introduction
12.10.4 Hologic, Inc. Revenue in Hospital-acquired Infection Diagnostics Business (2014-2019)
12.10.5 Hologic, Inc. Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
【免責事項】
https://www.globalresearch.jp/disclaimer